Get started
Author

Roberto Scarpioni

Observed names: R Scarpioni, R. Scarpioni, Scarpioni R., Scarpioni Roberto
Observed institutions: Karolinska University Hospital, Université de Versailles Saint-Quentin-en-Yvelines, Karolinska Institutet, Azienda Unità Sanitaria Locale Piacenza, Ospedaliera di Piacenza, Guglielmo da Saliceto Hospital
ORCID: 0000-0003-1809-0596
Observed ORCID: 0000-0003-1809-0596
OpenAlex ID: A5022862397
Dialysis-related amyloidosis: challenges and solutions
2016 · Roberto Scarpioni, Marco Ricardi, et al. · International Journal of Nephrology and Renovascular Disease · 147
PDF
Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: A meta-analysis of randomized controlled trials
2011 · Dharam J. Kumbhani, Anthony A. Bavry, et al. · American Heart Journal · 97
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients
2019 · Nicholas C. Chesnaye, Karolina Szummer, et al. · Journal of the American Heart Association · 74
PDF
Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage
2016 · Roberto Scarpioni, Marco Ricardi, et al. · World Journal of Nephrology · 72
PDF
Covid-19 and its impact on nephropathic patients: the experience at Ospedale "Guglielmo da Saliceto" in Piacenza.
2020 · Roberto Scarpioni, Alessandra Manini, et al. · Giornale Italiano di Nefrologia · 54
Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab
2014 · Roberto Scarpioni, Donato Rigante, et al. · Clinical Rheumatology · 47
Atherosclerotic renovascular disease: Medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression. The rationale and study design of a prospective, multicenter and randomized trial (NITER)
2005 · Roberto Scarpioni, Emanuele Michieletti, et al. · Journal of Nephrology · 45
Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins
2012 · Roberto Scarpioni, Marco Ricardi, et al. · World Journal of Nephrology · 37
PDF
A clinical stratification tool for chronic kidney disease progression rate based on classification tree analysis
2013 · P. Rucci, M. Mandreoli, et al. · Nephrology Dialysis Transplantation · 30
PDF
Renal involvement in autoinflammatory diseases and inflammasome-mediated chronic kidney damage.
2018 · Roberto Scarpioni, Laura Obici · PubMed · 25
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease
2021 · Ziad A Massy, Nicholas C Chesnaye, et al. · Clinical Kidney Journal · 24
PDF
Dyslipidemia in Chronic Kidney Disease: Are Statins Still Indicated in Reduction Cardiovascular Risk in Patients on Dialysis Treatment?
2010 · Roberto Scarpioni, Marco Ricardi, et al. · Cardiovascular Therapeutics · 24
Physical activity and exercise programs for kidney patients: an Italian survey of nephrology centres
2024 · Francesca Bulighin, Filippo Aucella, et al. · Journal of Nephrology · 22
PDF
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study
2021 · Boukje C Eveleens Maarse, Nicholas C Chesnaye, et al. · Clinical Kidney Journal · 21
PDF
Remote patient monitoring in peritoneal dialysis helps reduce risk of hospitalization during Covid-19 pandemic
2020 · Roberto Scarpioni, Alessandra Manini, et al. · Journal of Nephrology · 21
PDF
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease
2023 · Megan Astley, Fergus J Caskey, et al. · Clinical Kidney Journal · 18
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients
2022 · Chava L. Ramspek, Rosemarijn Boekee, et al. · Kidney International Reports · 18
PDF
Insulin Therapy in Uremic Diabetic Patients on Continuous Ambulatory Peritoneal Diaysis; Comparison of Intraperitoneal and Subcutaneous Administration
1994 · Lino Scarpioni, Sergio Ballocchi, et al. · Peritoneal Dialysis International · 18
Excess mortality attributable to chronic kidney disease. Results from the PIRP project
2015 · Dino Gibertoni, Marcora Mandreoli, et al. · Journal of Nephrology · 17
The PIRP project (Prevenzione Insufficienza Renale Progressiva): how to integrate hospital and community maintenance treatment for chronic kidney disease
2019 · Antonio Santoro, Dino Gibertoni, et al. · Journal of Nephrology · 14
Acute kidney injury, a common and severe complication in hospitalized patients during the COVID-19 pandemic
2021 · Roberto Scarpioni, Teresa Valsania, et al. · Journal of Nephrology · 13
PDF
Observational Retrospective Study on Patient Lifestyle in the Pretransplantation and Post-transplantation Period in the Emilia-Romagna Region
2020 · Valentina Totti, Tiziana Campione, et al. · Transplantation Proceedings · 13
Interaction between Albuminuria and Treatment Group Outcomes for Patients with Renal Artery Stenosis: The NITER Study
2018 · Efaza U. Siddiqui, Timothy P. Murphy, et al. · Journal of Vascular and Interventional Radiology · 13
Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD
2023 · Nicholas C Chesnaye, Fergus J Caskey, et al. · Nephrology Dialysis Transplantation · 12
PDF
Acute hydrothorax in a peritoneal dialysis patient: long-term efficacy of autologous blood cell pleurodesis associated with small-volume peritoneal exchanges
2003 · R. Scarpioni · Nephrology Dialysis Transplantation · 11
Works count: 58
Citation count: 948
H-index: 18
I10-index: 25
Year
Topic
Type